vs

Side-by-side financial comparison of AUBURN NATIONAL BANCORPORATION, INC (AUBN) and Cellectis S.A. (CLLS). Click either name above to swap in a different company.

Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $8.5M, roughly 1.1× AUBURN NATIONAL BANCORPORATION, INC). AUBURN NATIONAL BANCORPORATION, INC runs the higher net margin — 19.7% vs -265.9%, a 285.6% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs 8.4%). Cellectis S.A. produced more free cash flow last quarter ($27.6M vs $10.9M).

Auburn Bank is an American community bank providing services in the East of Alabama as a state registered bank. The Bank offers financial products and services including checking, savings, and lending. The bank is a member of the Federal Home Loan Bank of Atlanta. Its operation is regulated by the Alabama Superintendent of Banks.

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

AUBN vs CLLS — Head-to-Head

Bigger by revenue
CLLS
CLLS
1.1× larger
CLLS
$9.5M
$8.5M
AUBN
Growing faster (revenue YoY)
CLLS
CLLS
+366.6% gap
CLLS
375.0%
8.4%
AUBN
Higher net margin
AUBN
AUBN
285.6% more per $
AUBN
19.7%
-265.9%
CLLS
More free cash flow
CLLS
CLLS
$16.7M more FCF
CLLS
$27.6M
$10.9M
AUBN

Income Statement — Q4 FY2025 vs Q2 FY2024

Metric
AUBN
AUBN
CLLS
CLLS
Revenue
$8.5M
$9.5M
Net Profit
$1.7M
$-25.3M
Gross Margin
Operating Margin
25.1%
-181.1%
Net Margin
19.7%
-265.9%
Revenue YoY
8.4%
375.0%
Net Profit YoY
6.7%
-51.9%
EPS (diluted)
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUBN
AUBN
CLLS
CLLS
Q4 25
$8.5M
Q3 25
$8.4M
Q2 25
$8.1M
Q1 25
$7.8M
Q4 24
$7.8M
Q3 24
$7.6M
Q2 24
$7.6M
$9.5M
Q1 24
$7.5M
Net Profit
AUBN
AUBN
CLLS
CLLS
Q4 25
$1.7M
Q3 25
$2.2M
Q2 25
$1.8M
Q1 25
$1.5M
Q4 24
$1.6M
Q3 24
$1.7M
Q2 24
$1.7M
$-25.3M
Q1 24
$1.4M
Operating Margin
AUBN
AUBN
CLLS
CLLS
Q4 25
25.1%
Q3 25
33.9%
Q2 25
28.5%
Q1 25
24.7%
Q4 24
30.6%
Q3 24
29.6%
Q2 24
29.0%
-181.1%
Q1 24
20.3%
Net Margin
AUBN
AUBN
CLLS
CLLS
Q4 25
19.7%
Q3 25
26.5%
Q2 25
22.5%
Q1 25
19.6%
Q4 24
20.0%
Q3 24
22.7%
Q2 24
22.8%
-265.9%
Q1 24
18.2%
EPS (diluted)
AUBN
AUBN
CLLS
CLLS
Q4 25
Q3 25
$0.64
Q2 25
Q1 25
Q4 24
Q3 24
$0.50
Q2 24
$-0.28
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUBN
AUBN
CLLS
CLLS
Cash + ST InvestmentsLiquidity on hand
$149.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$92.1M
$148.6M
Total Assets
$1.0B
$407.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUBN
AUBN
CLLS
CLLS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$149.0M
Q1 24
Stockholders' Equity
AUBN
AUBN
CLLS
CLLS
Q4 25
$92.1M
Q3 25
$89.6M
Q2 25
$86.1M
Q1 25
$83.1M
Q4 24
$78.3M
Q3 24
$84.3M
Q2 24
$75.2M
$148.6M
Q1 24
$74.5M
Total Assets
AUBN
AUBN
CLLS
CLLS
Q4 25
$1.0B
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$996.8M
Q4 24
$977.3M
Q3 24
$990.1M
Q2 24
$1.0B
$407.1M
Q1 24
$979.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUBN
AUBN
CLLS
CLLS
Operating Cash FlowLast quarter
$12.3M
$28.9M
Free Cash FlowOCF − Capex
$10.9M
$27.6M
FCF MarginFCF / Revenue
128.3%
290.5%
Capex IntensityCapex / Revenue
17.5%
13.2%
Cash ConversionOCF / Net Profit
7.42×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUBN
AUBN
CLLS
CLLS
Q4 25
$12.3M
Q3 25
$4.1M
Q2 25
$2.1M
Q1 25
$2.6M
Q4 24
$10.8M
Q3 24
$1.9M
Q2 24
$3.1M
$28.9M
Q1 24
$3.1M
Free Cash Flow
AUBN
AUBN
CLLS
CLLS
Q4 25
$10.9M
Q3 25
Q2 25
Q1 25
Q4 24
$8.7M
Q3 24
Q2 24
$27.6M
Q1 24
FCF Margin
AUBN
AUBN
CLLS
CLLS
Q4 25
128.3%
Q3 25
Q2 25
Q1 25
Q4 24
111.6%
Q3 24
Q2 24
290.5%
Q1 24
Capex Intensity
AUBN
AUBN
CLLS
CLLS
Q4 25
17.5%
Q3 25
Q2 25
Q1 25
Q4 24
26.7%
Q3 24
Q2 24
13.2%
Q1 24
Cash Conversion
AUBN
AUBN
CLLS
CLLS
Q4 25
7.42×
Q3 25
1.83×
Q2 25
1.17×
Q1 25
1.72×
Q4 24
6.93×
Q3 24
1.08×
Q2 24
1.76×
Q1 24
2.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons